reference/27473759

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27473759

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	6
issn	0392-856X
issueIdentifier	2
pageRange	243-6
publicationName	Clinical and experimental rheumatology
startingPage	243
bibliographicCitation	Kuuliala A, Leirisalo-Repo M, Möttönen T, Hannonen P, Nissilä M, Kautiainen H, Korpela M, Julkunen H, Hakola M, Repo H; FIN-RACo Trial Group. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. Clin Exp Rheumatol. 2005 Mar;23(2):243–6. PMID: 15895898.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf15149d1c9f38fe09bee898f66ccbea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e21c456586b6329ee3e8446b1c549e43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52f81602e8b0e5ab242022781e825ed3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffdcc9c7a78093c4c43d46539c08fcd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c99e29328ee44218ba614c9de938250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d92553d968e9d28390cf89344d584009 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f267a8626314f6f9b0e7ebc4a5bc86f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_247aa01330af3040d66a24f0258d6dd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13767678cf760d12f93a4e7e6b943928 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6f6e318b1bae13ffbf5e7ef2232875
date	200503
identifier	https://pubmed.ncbi.nlm.nih.gov/15895898
isPartOf	https://portal.issn.org/resource/ISSN/0392-856X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3036
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug
discusses	http://id.nlm.nih.gov/mesh/M0023684 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0028429
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015375Q000097 http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D018501Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D019040Q000097 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D001172Q000097 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D006304 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001172Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6852147 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9109 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b88d5e2508c1ccf58e9fddfe115c0ae

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129756062 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276

Total number of triples: 58.